Ha Chul Shin

Statistics

Publications

Citations

156

H-Index

Active since

2016

Affiliations

Asan Medical Center(Current)

Pharmicell (South Korea)

University of Ulsan

Ulsan College

Kangwon National University Hospital

Ha Chul Shin is an author at Asan Medical Center specializing in mesenchymal stromal cell therapy, regenerative medicine, and mesenchymal stem cell therapy.

ORCID

Publications per year

2016–2021

Publications

Mesenchymal Stem Cell–Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma

A‐Rum Yoon, JinWoo Hong, Yan Li et al. · Cancer Research · 2019 · 90 citations

Pharmacy, Cancer Biology, Oncology +16

Safety of autologous bone marrow-derived mesenchymal stem cells in erectile dysfunction: an open-label phase 1 clinical trial

Dalsan You, Myoung‐jin Jang, Geehyun Song et al. · Cytotherapy · 2021 · 33 citations

Medicine, Urology, Regenerative Medicine +15

Hypoxic Preconditioned Mesenchymal Stromal Cell Therapy in a Rat Model of Renal Ischemia-reperfusion Injury: Development of Optimal Protocol to Potentiate Therapeutic Efficacy

Myoung‐jin Jang, Dalsan You, Jin Young Park et al. · International Journal of Stem Cells · 2018 · 18 citations · Full text

Medicine, Nephrology, Cell Therapy +14

Bone marrow–derived mesenchymal stromal cell therapy in a rat model of cavernous nerve injury: Preclinical study for approval

Dalsan You, Myoung‐jin Jang, Bo Hyun Kim et al. · Cytotherapy · 2016 · 15 citations

Medicine, Neuroscience, Neurosurgery +12

1–4 of 4